Antibiotic-associated diarrhea

Antibiotics are a powerful tool in the fight against bacterial infections. While treatments sometimes appear to be without obvious short-term side effects, the gut microbiota imbalance they provoke can cause diarrhea in up to 35% of patients.1-3 This antibiotic-associated diarrhea (AAD) can at times cloak serious intestinal infections.3

The gut microbiota Probiotics
Antibiotic-associated diarrhea

How do antibiotics unbalance the gut flora?

While antibiotics eradicate the (sidenote: Pathogen A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) responsible for infection, they can also destroy some of the beneficial bacteria in your microbiota, systematically causing an imbalance of varying degrees in this ecosystem. This imbalance (known as (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) ) causes AAD, as the gut microbiota is less able to perform its protective functions. AAD can affect up to 35% of patients1-3 and up to 80% of children receiving antibiotic treatment.1

Image
antibiotics EN

Furthermore, while the gut microbiota shows a certain degree of resilience (i.e. it reverts to a composition similar to that existing before the antibiotic-induced imbalance), it does not always fully recover.4,5 Recent research has shown that antibiotics can alter the diversity and abundance of bacteria, and that this imbalance can be prolonged (usually 8-12 weeks after the end of treatment).1,6

Image
microbiote-antibiotique-focus1_EN

In most cases, diarrhea without further symptoms 

The main short-term consequence of antibiotic treatment is the altered bowel movements experienced by some patients, most often resulting in diarrhea. AAD is defined as three or more very loose or liquid stools within 24 hours of the beginning of antibiotic treatment or up to 2 months after its cessation.7-9 Its incidence depends on several factors, including age, context and the type of antibiotic. The diarrhea is usually mild to moderate in intensity and in the vast majority of cases is functional, i.e. associated with a gut microbiota imbalance.1 Antibiotics with the broadest spectrum of antimicrobial activity (i.e. that act on a very wide range of bacteria) are associated with higher rates of diarrhea.3

Antibiotics save life! Did you know that they also have an impact on your microbiota? Did you know that the misuse and overuse of antibiotics can lead to antibiotic resistance? Have you heard about the World AMR Awareness Week (WAAW)? All the answers in this dedicated page:

Antibiotics: what impact on the microbiota and on our health?

Learn more

However, in 10%-20% of cases the diarrhea results from an infection by Clostridioides difficile (C. difficile), a bacterium that can become pathogenic due to certain factors, such as antibiotic use, being older than 65 or being affected by certain associated conditions.3 The colonization of the gut microbiota by this bacterium triggers an inflammatory reaction, with clinical consequences ranging from moderate diarrhea to much more serious symptoms, including death.3

Is ending antibiotic use the most effective treatment?

The management of AAD depends on the symptoms and the pathogen (e.g. C. difficile).10 For mild to moderate diarrhea, treatment involves ending antibiotic use (or replacing the antibiotic with one less likely to cause diarrhea) to allow the microbiota to recover and the patient to rehydrate.10

Numerous studies have shown that probiotics may help reconstitute the gut microbiota, while some probiotics have proven effective in preventing and treating AAD.6,11,12 When taken during antibiotic treatment, other probiotics have been shown to reduce the risk of primary and secondary infection with C. difficile.13-15 Lastly, fecal microbiota transplantation (naturally transferring a healthy microbiota into a sick individual in order to restore his or her microbial ecosystem) is currently only used for the most serious infections, i.e. relapses of infections with C. difficile.16,17

This article is based on scientifically approved sources but is not a substitute for medical advice. If you or your child display symptoms, please consult your family doctor or pediatrician.

What is the World AMR Awareness Week?

Each year, since 2015, the WHO organizes the World AMR Awareness Week (WAAW), which aims to increase awareness of global antimicrobial resistance. 

Antimicrobial resistance occurs when bacteria, viruses, parasites and fungi change over time and no longer respond to medicines. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become increasingly difficult or impossible to treat, increasing the risk of disease spread, severe illness and death.


Held on 18-24 November, this campaign encourages the general public, healthcare professionals and decision-makers to use antibiotics, antivirals, antifungals and antiparasitics carefully, to prevent the further emergence of antimicrobial resistance. 

Sources

1 McFarland LV, Ozen M, Dinleyici EC et al. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol. 2016;22(11):3078-3104.

2  Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334-9.

3  Theriot CM, Young VB. Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. Annu Rev Microbiol. 2015;69:445-461.

4 Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108 Suppl 1(Suppl 1):4554-4561.

5  Francino MP. Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Front Microbiol. 2016;6:1543.

6 Kabbani TA, Pallav K, Dowd SE et al. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes. 2017;8(1):17-32.

7 Wiström J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001 Jan;47(1):43-50. 

8 McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis. 1998 Sep-Oct;16(5):292-307. 

9 Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531-4. 

10 Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ. 2002 Jun 8;324(7350):1345-6. 

11 Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015 Oct;42(7):793-801. 

12 Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012 May 9;307(18):1959-69. 

13 McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994 Jun 22-29;271(24):1913-8. 

14 Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005 Mar 1;21(5):583-90. 

15 McFarland LV. Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review. Antibiotics (Basel). 2015 Apr 13;4(2):160-78. 

16 Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013 Apr;108(4):478-98; quiz 499.

17 Li YT, Cai HF, Wang ZH, et al. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment Pharmacol Ther. 2016 Feb;43(4):445-57.

 

BMI-21.28
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Infantile colic

“My newborn baby’s cry is the most heartbreaking sound I’ve ever heard”.1 So confess many parents who turn up helpless at their pediatrician’s office, unable to soothe their baby’s inexplicable cries. The symptoms are often difficult to identify and can be an ordeal for parents, and so it’s important to know how to recognize and understand them. Does the answer lie in your baby’s gut microbiota?

The gut microbiota
Infantile colic

What is infantile colic?

Infantile colic is characterized by excessive crying for unknown reasons in otherwise healthy infants. Gastrointestinal disorders (e.g. immaturity of the gastrointestinal tract, an allergy or intolerance to cow’s milk, stomach reflux)2 are mainly to blame,3 but other causes unrelated to the gastrointestinal system,3 such as parental stress,4 or maternal smoking, have also been studied.2

Colic is common in babies, but its symptoms, such as persistent crying, can cause distress in parents.

 

Did you know? 

The word “colic” comes from the Greek “κoλικóς” (kolikos), in reference to the colon. However, despite years of research, the cause of infantile colic remains unknown and it is not entirely certain that the intestines (and therefore the colon) are involved.5

What are the symptoms of infantile colic?

The baby cries a lot, is inconsolable, grimaces and may have a red face. It keeps its fists clenched and may have gas.5 Pediatricians have long used the “rule of three” to diagnose infantile colic.6 Introduced in 1954, these criteria have since been adapted by an international organization to give a new definition with the following criteria: recurrent and prolonged periods of restlessness, crying or irritability without obvious cause such as stunted growth, fever or ill health, and which cannot be prevented or resolved by the caregivers.7

What is the gut microbiota’s role?

A link between infantile colic and the gut microbiota – also known as the gut flora – has recently been established.8 Studies have shown that the gut microbiota of infants affected by colic differs from that of other babies:9


This gut microbiota imbalance, known as a “ (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) ”, appears to be strongly linked to colic: according to one hypothesis, an altered gut microbiota composition modifies intestinal motility (the way in which food moves through the digestive system), resulting in excessive production of gas.5

Gut inflammation: follow the calprotectin

The protein calprotectin can be used to identify gut inflammation. It is found in large quantities in infants suffering from colic and is associated with reduced gut microbiota diversity.9

How to help babies... and parents?

The family doctor is still the first port of call to diagnose infant colic and reassure parents. There is no cure10 for colic, but a few simple daily practices can help relieve the symptoms. These include breastfeeding, carrying your baby and balancing your child’s gut microbiota, particularly using probiotics.5 Probiotics appear to be a promising avenue, since the intake of “good” bacteria for a few months may reduce gut inflammation6 and help shorten the daily duration of crying.11 Since they help maintain a good intestinal balance, probiotics can also be used as a preventative measure.5

This article is based on scientifically approved sources but is not a substitute for medical advice. If your child displays symptoms, please consult your family doctor or pediatrician.

Sources

1 Groopman J. The Colic Conundrum. The crying that doctors can’t stop. Annals of Medicine, Sept 17, 2007 Issue. https://www.newyorker.com/magazine/2007/09/17/the-colic-conundrum

2 konieczna-Żydecka K, Janda K, Kaczmarczyk M, et al. The Effect of Probiotics on Symptoms, Gut Microbiota and Inflammatory Markers in Infantile Colic: A Systematic Review, Meta-Analysis and Meta-Regression of Randomized Controlled Trials. J Clin Med. 2020 Apr 2;9(4):999.

3 Gupta SK. Is colic a gastrointestinal disorder? Curr Opin Pediatr. 2002 Oct;14(5):588-92. 

4 van den Berg MP, van der Ende J, Crijnen AA, et al. Paternal depressive symptoms during pregnancy are related to excessive infant crying. Pediatrics. 2009 Jul;124(1):e96-103. 

Indrio F, Dargenio VN, Giordano P, et al. Preventing and Treating Colic. Adv Exp Med Biol. 2019;1125:49–56.

WESSEL MA, COBB JC, JACKSON EB, et al. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics. 1954 Nov;14(5):421-35. 

Zeevenhooven J, Koppen IJ, Benninga MA. The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers. Pediatr Gastroenterol Hepatol Nutr. 2017 Mar;20(1):1-13. 

8 Verduci E, Arrizza C, Riva E, et al. Microbiota and infantile colic: what’s new? Int J Probiotics Prebiotics. 2013; 8(1):25–28

Rhoads JM, Collins J, Fatheree NY, et al. Infant Colic Represents Gut Inflammation and Dysbiosis. J Pediatr. 2018 Dec;203:55-61.e3. 

10 Daelemans S, Peeters L, Hauser B, et al. Recent advances in understanding and managing infantile colic. F1000Res. 2018 Sep 7;7:F1000 Faculty Rev-1426. 

11 Sung V, D'Amico F, Cabana MD, et alLactobacillus reuteri to Treat Infant Colic: A Meta-analysis. Pediatrics. 2018 Jan;141(1):e20171811. 

12 O'Callaghan A, van Sinderen D. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front Microbiol. 2016 Jun 15;7:925.

13 Ruiz L, Delgado S, Ruas-Madiedo P, et al. Bifidobacteria and Their Molecular Communication with the Immune System. Front Microbiol. 2017 Dec 4;8:2345.

14 W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel 

15 Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004 Jun;70(6):3189-94.

16 Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013 Jun;109(11):1999-2007.

BMI-21.18

 

Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Vaginal yeast infection

Is the microbiota involved in vaginal yeast infections?

70%-75% of women suffer from a vaginal yeast infection (vaginal candidiasis) at least once in their life.1 Symptoms of the disease, such as itching and abnormal vaginal discharge, can be particularly troublesome in everyday life. Do vaginal microbiota imbalances facilitate infection?2

The vaginal microbiota
Vaginal microbiota

What is a vaginal yeast infection?

A vaginal yeast infection is an infection of the vulva and the vagina caused by a yeast-like fungus, in most cases Candida albicans3. After bacterial vaginosis, it is the second most common infectious vaginal disease.1 It is important to consult a doctor to confirm diagnosis, since its symptoms are not very specific. The most common clinical symptoms are abnormal vaginal discharge (leukorrhea), genital itching, and a burning sensation accompanied by vaginal pain or irritation that can lead to (sidenote: Dyspareunia Recurrent or persistent genital pain during sexual intercourse. ) or (sidenote: Dysuria Painful urination, often described by the patient as a burning, tingling or itching sensation. ) .1

42% Fewer than 1 in 2 women say that their doctor has ever explained to them how to maintain a balanced vaginal microbiota or educated on the importance of preserving as much as possible the balance of their vaginal microbiota

Is the vaginal microbiota involved?

Every woman’s vaginal microbiota is unique and, unlike other microbiota, the vaginal microbiota is well-balanced when its diversity is low4 Species of the genus (sidenote: Lactobacilli Rod-shaped bacteria whose main characteristic is the production of lactic acid, from where they get the name “lactic acid bacteria”.  Lactobacilli are present in the oral, vaginal and gut microbiota of humans, but also in plants and animals. They are found in fermented foods, such as dairy products (e.g. certain cheeses and yoghurts), pickles, sauerkraut, etc. Lactobacilli are also found in probiotics, with certain species recognized for their beneficial properties.   W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria, 2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004 Jun;70(6):3189-94. Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013 Jun;109(11):1999-2007. ) dominate the vaginal microbiota,4 but yeasts such as Candida albicans are also found in smaller quantities.5

The vaginal ecosystem evolves over the course of a woman’s life.6 This change is normal and is influenced by the menstrual cycle, puberty and the menopause, sexual activity, contraception, intimate hygiene, and pregnancy.7,8,9

A (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) is when the vaginal ecosystem is unbalanced (due to antibiotic treatment, douching, stress, smoking, etc.)2,6: species of Lactobacillus no longer predominate and instead certain (sidenote: Opportunistic infection An infection caused by a microorganism that is normally non-pathogenic, but which becomes so when the host microbiota loses its balance (through factors such as a weakened immune system, disease, age, certain medication, etc.). ) species may proliferate. This is what happens with vaginal candidiasis: Candida – yeasts normally present in the vagina and the gut5 – proliferate abnormally and become pathogenic under specific conditions. It is estimated that 10%-30% of women contract yeast infections following antibiotic treatment.10

10%-30% of women contract yeast infections following antibiotic treatment

Other factors that can increase the risk of infection1 include corticosteroid use, pregnancy, immunosuppressive diseases, poorly controlled diabetes, oral contraception, and IUD. Many factors have been identified but the mechanisms are not yet fully understood.11

Antifungals and probiotics

The classic treatment for vaginal yeast infections is antifungal medication administered orally or topically.11 However, relapses can occur and new therapeutic approaches are currently being evaluated.11 Recent work suggests that oral or topical probiotics (capsules or vaginal suppositories) may rebalance the vaginal microbiota and reduce the frequency of relapse.12,13

To reduce the risk of infection, certain intimate hygiene practices are recommended14 – daily habits to help care for your vaginal microbiota.  

This article is based on scientifically approved sources. If you experience symptoms, please consult your family doctor or gynecologist.

Sources

1 Gonçalves B, Ferreira C, Alves CT, et al. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016 Nov;42(6):905-27. 

2 Riepl M. Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome. Int J Pharm Compd. 2018 Nov-Dec;22(6):456-465.

3 Ceccarani C, Foschi C, Parolin C, et al. Diversity of vaginal microbiome and metabolome during genital infections. Sci Rep. 2019 Oct 1;9(1):14095.

4 Gupta S, Kakkar V, Bhushan I. et al. Crosstalk between Vaginal Microbiome and Female Health: A review. Microb Pathog. 2019 Aug 23;136:103696.

5 d'Enfert C, Kaune AK, Alaban LR, et al. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev. 2020 Nov 24:fuaa060. 

6 Amabebe E, Anumba DOC. The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. Front Med (Lausanne). 2018 Jun 13;5:181.

7 Gupta P, Singh MP, Goyal K. Diversity of Vaginal Microbiome in Pregnancy: Deciphering the Obscurity. Front Public Health. 2020 Jul 24;8:326.

8 Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019 Apr;220(4):324-335.

9 Lewis FM, Bernstein KT, Aral SO. Vaginal Microbiome and Its Relationship to Behavior, Sexual Health, and Sexually Transmitted Diseases. Obstet Gynecol. 2017;129(4):643-654.

10  Shukla A, Sobel JD. Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure. Curr Infect Dis Rep. 2019 Nov 9;21(11):44.

11 de Cássia Orlandi Sardi, J, Silva, D.R, et al. Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options. Curr Fungal Infect Rep 15, 32–40 (2021). 

12 Strus M, Chmielarczyk A, Kochan P, et al. Studies on the effects of probiotic Lactobacillus mixture given orally on vaginal and rectal colonization and on parameters of vaginal health in women with intermediate vaginal flora. Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):210-5. 

13 Vujic G, Jajac Knez A, Despot Stefanovic V, et al. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2013 May;168(1):75-9. 

14 Chen Y, Bruning E, Rubino J, et al. Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage. Womens Health (Lond). 2017 Dec;13(3):58-67.

15 Hill DA, Taylor CA. Dyspareunia in Women. Am Fam Physician. 2021 May 15;103(10):597-604.

16 Wrenn K. Dysuria, Frequency, and Urgency. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 181. 

17 Brown SP, Cornforth DM, Mideo N. Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends Microbiol. 2012 Jul;20(7):336-42.

18 W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria, 2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel 

BMI-21.21
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Bacterial vaginosis - vaginal microbiota imbalance

The most common gynecological disorder in women of childbearing age, bacterial vaginosis affects 23%-29% of women worldwide.1 The disorder is hit and miss: it can go completely unnoticed or significantly alter a woman’s life. The cause remains unknown, but a vaginal microbiota imbalance seems the most likely explanation.2

The vaginal microbiota
Is bacterial vaginosis a disease?

What is bacterial vaginosis?

Bacterial vaginosis is a harmful and hard to detect disorder. 50% of women are asymptomatic, while others suffer from local irritation or foul-smelling discharge.3

In practice, doctors use the Amsel score4 to diagnose bacterial vaginosis. Diagnosis is based on the presence of at least three of the following criteria:

  • Thin, homogeneous vaginal discharge 
  • A vaginal pH above 4.5 
  • An amine smell (similar to a fishy smell) after a specific test is performed on a vaginal smear
  • Presence of vaginal tissue cells coated with bacteria when discharge is examined microscopically

Many risk factors are associated with the disease, including age, menstrual cycle, pregnancy, and sexual history, but also vaginal douching and smoking.3 A vaginal dysbiosis induced by antibiotic treatment may also participate in the development of bacterial vaginosis, creating a vicious circle, since antibiotics can be used to treat the infection.3

Lastly, women with bacterial vaginosis are more likely to contract sexually transmitted infections (STIs), including herpes, HPV, AIDS and bacterial infections.5,6

50% of women are asymptomatic, while others suffer from local irritation or foul-smelling discharge

Is there a link with the vaginal microbiota?

Bacterial vaginosis is associated with an imbalance ( (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) ) of the vaginal microbiota.2 The vaginal microbiota is dominated by different species of the bacterial genus (sidenote: Lactobacilli Rod-shaped bacteria whose main characteristic is the production of lactic acid, from where they get the name “lactic acid bacteria”.  Lactobacilli are present in the oral, vaginal and gut microbiota of humans, but also in plants and animals. They are found in fermented foods, such as dairy products (e.g. certain cheeses and yoghurts), pickles, sauerkraut, etc. Lactobacilli are also found in probiotics, with certain species recognized for their beneficial properties.   W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria, 2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004 Jun;70(6):3189-94. Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013 Jun;109(11):1999-2007. ) . These bacteria help maintain an acidic pH in the vagina and thus prevent the proliferation of pathogenic bacteria.7 The vaginal microbiota also contains yeasts such as Candida albicans in smaller quantities.8


With bacterial vaginosis, this normal microbial flora is replaced by a polymicrobial flora comprising numerous bacteria (Gardnerella, Atopobium, Prevotella, Mobiluncus, etc.).2 This leads to an increase in the pH of the vagina (which is normally very acidic), mainly attributed to the decrease in the predominance of Lactobacillus species.9 However, the mere presence of species from this polymicrobial flora does not in itself seem to cause infection, i.e. a woman whose vagina contains Atopobium or Prevotella species will not necessarily report symptoms. In fact, Gardnerella vaginalis is present in 90% of symptomatic subjects and 45% of healthy subjects.4 For a long time, this bacterium was considered the main pathogen behind bacterial vaginosis, but new research has shown that Gardnerella vaginalis can colonize the vagina without triggering infection.10 The causes of the infection are yet to be determined and research in the area continues.3

35% Only 1 in 3 women know that bacterial vaginosis is associated with an imbalance in the vaginal microbiota

69% Almost 7 out of 10 women are aware that antibiotics can alter the vaginal microbiota.

How to avoid bacterial vaginosis

Treatment is only recommended for women who are symptomatic. Recommended treatment currently involves the prescription of oral or vaginal antibiotics.2 While antibiotics may help alleviate symptoms, relapse is unfortunately very common.11

However, there are a number of ways to reduce your chances of getting bacterial vaginosis. Firstly, avoid certain risk factors, such as vaginal douching or smoking.3 Vaginal or oral probiotics,12,13 that restore the balance of the vaginal microbiota can be used to treat or prevent relapses.

This article is based on scientifically approved sources. If you experience symptoms, please consult your family doctor or gynecologist.

Sources

1  Peebles K, Velloza J, Balkus JE, et al. High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2019 May;46(5):304-311. 

2 Chen X, Lu Y, Chen T, et al. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021 Apr 7;11:631972. 

3 Coudray MS, Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2019 Dec 24;245:143-148

4 Onderdonk AB, Delaney ML, Fichorova RN. The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev. 2016 Apr;29(2):223-38. 

5 Lewis FM, Bernstein KT, Aral SO. Vaginal Microbiome and Its Relationship to Behavior, Sexual Health, and Sexually Transmitted Diseases. Obstet Gynecol. 2017;129(4):643-654.

6 Torcia MG. Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections. Int J Mol Sci. 2019;20(2):266.

7 Greenbaum S, Greenbaum G, Moran-Gilad J, et al. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019 Apr;220(4):324-335.

8 d'Enfert C, Kaune AK, Alaban LR, et al. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev. 2020 Nov 24:fuaa060. 

9 Aldunate M, Srbinovski D, Hearps AC, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015 Jun 2;6:164. 

10 Muzny CA, Taylor CM, Swords WE, et al. An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis. J Infect Dis. 2019 Sep 26;220(9):1399-1405. 

11 Bradshaw CS, Brotman RM. Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure. BMC Infect Dis. 2015 Jul 29;15:292. 

12 López-Moreno A, Aguilera M. Vaginal Probiotics for Reproductive Health and Related Dysbiosis: Systematic Review and Meta-Analysis. J Clin Med. 2021 Apr 2;10(7):1461. 

13 Koirala R, Gargari G, Arioli S, et al. Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study. FEMS Microbiol Ecol. 2020 Jun 1;96(6):fiaa084. 

BMI-21.22
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Travelers’ diarrhea

It's not what you think...

Notice to globetrotters and travelers who’ve fallen victim to the dreaded “tourista”: this mostly benign infection which disrupts the gut microbiota1 is actually called travelers’ diarrhea. A very common disease, it occurs in 10% to 40% of tourists2 on a two-week trip, depending on the country visited and the characteristics of the traveler. It affects up to 60% of travelers in tropical or subtropical regions.Although different in many ways from gastroenteritis, both diseases cause diarrhea.2

The gut microbiota Antibiotic-associated diarrhea
Travelers’ diarrhea

What is travelers’ diarrhea?

Contrary to popular belief, travelers’ diarrhea is not caused by exotic foods poorly digested by unaccustomed stomachs. It is a real infection most frequently caused by bacteria  (Escherichia coli, Salmonella, Shigella, Campylobacter).2 It may also be caused by a parasite (Giardia, Cryptosporidium, etc.)2 or a virus (norovirus, rotavirus).2 The pathogen responsible for the diarrhea is identified in only 40%-60% of symptomatic travelers.4 The main source of the microorganisms involved are contaminated food (especially raw vegetables, undercooked meat or fish, unpeeled fruit, etc.) and contaminated water.5 It can also be transmitted through contact with other people when hygiene rules are not respected.5

40%-60% The pathogen responsible for the diarrhea is identified in only 40%-60% of symptomatic travelers

What is the microbiota’s role? 

One of the gut microbiota’s roles is to prevent or limit the invasion of the intestine by (sidenote: Pathogens A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) .6 Although common, the “tourista” is not without consequences. Regardless of the pathogen, diarrhea disrupts the balance of the gut microbiota at least temporarily, leading to (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) .1 This imbalance may have long-term consequences, including an increased risk of developing post-infectious7 irritable bowel syndrome, which occurs in 3%-17% of patients.2 A research team recently showed that gut microbiota diversity was significantly lower in Swedish travelers who contracted a Campylobacter infection than in travelers who remained uninfected.8 Another research team found that diarrhea during travel was associated with a higher relative abundance in the gut of a specific bacteria (Prevotella copri) before departure and after return.9 Could travelers’ gut microbiota composition be used to predict the risk of developing diarrhea during the trip? Since there are still very few studies in this area, it remains to be confirmed.

What are the symptoms of traveler’s diarrhea?

The symptoms and duration vary depending on the cause4 (bacterial, parasitic or viral), but on average symptoms last 4-5 days without treatment.2 In addition to frequent loose or watery stools (at least 3 per day),5 at least one of the following symptoms must be present: fever, nausea, vomiting, abdominal cramps or an urgent need to go to the bathroom.2 The major risk is dehydration resulting from the loss of fluids through watery diarrhea. At-risk individuals (children, the elderly, or those with chronic conditions that weaken the immune system2) are more likely to be hospitalized.

Definition of travelers' diarrhea:

Mild

Tolerable diarrhea that does not interfere with planned activities.

Moderate

Diarrhea that restricts or interferes with planned activities.

Severe

Disabling diarrhea that results in complete inability to perform planned activities. Dysentery, i.e. diarrhea accompanied by blood and/or mucus, is considered a type of severe diarrhea.

Persistent

Diarrhea that lasts more than two weeks.

How to prevent and treat travelers’ diarrhea

The prevention of travelers’ diarrhea mainly involves hygiene measures such as frequent hand washing and food precautions.5 Ask your doctor or pharmacist for advice before traveling. Rehydration is key to treating travelers’ diarrhea:5 clean water (bottled water, etc.) or herbal teas drunk often and in small quantities. Any lightly sweetened and/or salted food is recommended (solid foods are not contraindicated).4 Antidiarrheal drugs help reduce the risk of dehydration and may be recommended in some cases.10 Antibiotics may also be necessary. However, antibiotics can lead to a reduction in the diversity of the gut microbiota, which thus loses its ability to act as a barrier against (sidenote: Pathogen A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) . Moreover, antibiotic use can lead to the selection of antibiotic-resistant bacteria.11 For this reason, they are only recommended for severe diarrhea, and in some cases for moderate diarrhea,10 under the supervision of a doctor. Probiotics may be useful as a preventive measure12, and to limit the intensity and duration of symptoms.13,14

This article is based on scientifically approved sources but is not a substitute for medical advice. If you experience symptoms, please consult your family doctor.

Sources

Youmans BP, Ajami NJ, Jiang ZD et al. Characterization of the human gut microbiome during travelers’ diarrhea. Gut Microbes. 2015;6(2):110-9. 

Steffen R, Hill DR, DuPont HL. Traveler's diarrhea: a clinical review. JAMA. 2015 Jan 6;313(1):71-80. 

Eckbo EJ, Yansouni CP, Pernica JM, et al. New Tools to Test Stool: Managing Travelers' Diarrhea in the Era of Molecular Diagnostics. Infect Dis Clin North Am. 2019 Mar;33(1):197-212.

Fedor A, Bojanowski I, Korzeniewski K. Gastrointestinal infections in returned travelers. Int Marit Health. 2019;70(4):244-251. 

World Health Organization. 2017. Diarrhoeal disease. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs330/en/. Accessed 28 October 2017.

Riddle MS, Connor BA. The Traveling Microbiome. Curr Infect Dis Rep. 2016 Sep;18(9):29.

Beatty JK, Bhargava A, Buret AG. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol. 2014 Apr 14;20(14):3976-85. 

Kampmann C, Dicksved J, Engstrand L, et al. Composition of human faecal microbiota in resistance to Campylobacter infection. Clin Microbiol Infect. 2016 Jan;22(1):61.e1-61.e8.

Leo S, Lazarevic V, Gaïa N, et al. The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions. Gut Microbes. 2019;10(5):631-641.

10 Riddle MS, Connor BA, Beeching NJ, et al. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med. 2017 Apr 1;24(suppl_1):S57-S74.

11 McDonald LC. Effects of short- and long-course antibiotics on the lower intestinal microbiome as they relate to traveller's diarrhea. J Travel Med. 2017 Apr 1;24(suppl_1):S35-S38.

12 McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010 May 14;16(18):2202-22. 

13 Dinleyici EC, Eren M, Ozen M, et al. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther. 2012 Apr;12(4):395-410.

14 Allen SJ, Martinez EG, Gregorio GV, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003048. 

15 Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. 

BMI 21.20
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

The skin microbiota

The skin microbiota: why is it so important?

skin microbiota

35% only 1 in 3 people knew that it was better not to wash twice a day to preserve their skin’s microbiota

What exactly is the skin microbiota?

Let’s start by focusing on the skin, the largest organ in the human body and its first line of defense. The skin acts as a triple protective barrier:1,2

  • a physical barrier that protects the internal organs from the external environment3
  • a chemical barrier: dry and rich in salt and acidic compounds, the skin is a hostile environment for many microorganisms4
  • an immune barrier, thanks to defense cells in the skin that prevent colonization and infection by pathogenic microbes2

Despite this, the skin is home to its own distinctive microbiota which includes bacteria (Cutibacterium acnes, Staphylococcus epidermidis, etc.), fungi (e.g. Malassezia), viruses (e.g. papillomavirus) and parasites (including mites such as Demodex). These microorganisms live in perfect harmony and together form the skin microbiota.1,5

As you may have noticed, your skin changes from one part of the body to another: 

  • drier on the forearm and the palms of the hand.1,5
  • oilier on the face, chest and back.1,5
  • and more humid in the armpits, the elbow fold, the nostrils, on the back of the knee and on the groin.1,5

Each of these skin sites is home to a distinct microbiota adapted to its specific environment1. Some researchers also distinguish a fourth site in the foot (nails, heel and space between toes).1
In addition to these variations across the skin’s surface, there are also variations according to depth or skin layer: the deeper you go into the dermis, the fewer the (sidenote: Microorganisms Living organisms too small to see with the naked eye. This includes bacteria, viruses, fungi, archaea, protozoa, etc., collectively known as ’microbes’. Source: What is microbiology? Microbiology Society. ) and the more similar these microorganisms are from one person to next.6

How does the skin microbiota change throughout life?

The skin microbiota is relatively stable over time1,5 and only changes at the major stages of life. 

At birth, children born vaginally are passed on vaginal bacteria (Lactobacillus, C. albicans), while those born by caesarean section receive skin microbes (Staphylococcus, Streptococcus). At puberty, the rate of secretion of growth hormones explodes. The skin becomes oilier and selects more well-adapted microorganisms that live on through adulthood. The skin gradually changes as it ages, with a weakened immune system, reduced cell renewal, less sweat, and altered sebum production.7,8

These physiological changes modify the skin environment and alter the microbial balance7, which becomes more diverse and sees a change in dominance in bacterial groups.8

Why is the skin microbiota a key factor in skin health?

The skin microbiota knows how to thank its host for giving it food and shelter. It protects the host from (sidenote: Pathogens A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) through its physical presence on the skin and by secreting antibacterial molecules and acids.2 But that’s not all. The skin microbiota also plays a key role in immunity: it stimulates the immune defense mechanisms of the epidermis and the body as a whole and calms inflammation where necessary.4

What diseases are associated with an unbalanced skin microbiota?

The composition of the skin microbiota is mostly influenced by host characteristics (age, sex, genes, immune status, diet, stress levels) and the environment (lifestyle, domestic and personal hygiene, living arrangements, geographical location, sun exposure, etc.).2 At times, factors such as stress, a lifestyle change or the use of medication (e.g. antibiotics) or personal hygiene products disrupt the balance of the microbiota: bacteria previously beneficial to the host take the upper hand and become pathogenic.1 Many common skin diseases are associated with changes in the microbiota. This situation is known as a (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) .1

Dysbiosis is often associated with pathological skin conditions such as acne,9 atopic dermatitis,10 psoriasis,11 seborrheic dermatitis,12 rosacea13 or skin cancer.14 Changes in the skin microbiota can also be observed in non-pathological skin conditions such as sensitive skin, sensations of discomfort or irritation, or diaper rash. The skin is constantly exposed to various external factors linked to lifestyle (cold, heat, sun, UV, hygiene products, etc.) or the individual (genes, sensitivity, allergies, etc.) that can affect the physical, mechanical or microbial properties of the skin barrier.15 The microbiota is also involved in wound healing16 and body odor.17

The gut-skin axis

The gut and the skin are intimately linked. The communication channel between them is known as gut-skin axis. Several common skin diseases, such as acne, atopic dermatitis, psoriasis and rosacea have been associated with gut dysbiosis.18

How can you take care of your skin microbiota? 

You now know the importance of the skin microbiota for the health of your skin, and that the gut microbiota also plays a role in skin health. So how can you take care of the various microbiota so that your skin stays healthy? Many researchers have looked into this question. Unfortunately, the answer isn’t as straightforward as using beneficial bacteria or yeast to replenish or enrich the existing microbiota or replace a microbiota that’s not up to the job. Instead, the idea is to modify the microbiota so that it functions correctly, thus improving host health. How? There are several ways to improve the balance and diversity of the gut microbiota, each with its own characteristics:

Oral preparation: 

The existence of a gut-skin axis raises hope that we may be able improve the health of the skin by modulating the gut microbiota by taking probiotic, prebiotic and symbiotic supplement or through a better diet:

  • Probiotics are living microorganisms that confer a health benefit on the host when applied in appropriate quantities19,20. For certain inflammatory skin diseases, the use of specific probiotics appears to be effective.14
  • Prebiotics are specific non-digestible dietary fibers that confer a health benefit. They are selectively used by beneficial microorganisms in the host microbiota.21,22 Symbiotics23 mixture containing both prebiotic and probiotic have shown promising results in atopic dermatitis.24
  • Diet, the diversity and quality of what we eat contributes to the balance of our gut microbiota.25,26 A poorly balanced diet can affect the composition of the gut and give rise to certain conditions.27 To keep our gut in shape we should know what foods have a beneficial or adverse effect on it.28

Topical preparations

While few studies existed, products applied to the skin that contain certain probiotics, prebiotics or both, have shown positive resulted in improving the skin's health of patient with skin condition.14,24

However, clinical trials are still required to optimize their formulation. Hence the importance of following our latest news on the skin microbiota.

All the information in this article comes from scientific approved sources. Keep in mind this is not exhaustive. Here are all the studies from which we took all of that information.

Sources

Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143-155.

Egert M, Simmering R, Riedel CU. The Association of the Skin Microbiota With Health, Immunity, and Disease. Clin Pharmacol Ther. 2017 Jul;102(1):62-69.

Ederveen THA, Smits JPH, Boekhorst J et al. Skin microbiota in health and disease: From sequencing to biology. J Dermatol. 2020 Oct;47(10):1110-1118.

Flowers L, Grice EA. The Skin Microbiota: Balancing Risk and Reward. Cell Host Microbe. 2020;28(2):190-200.

Barnard E, Li H. Shaping of cutaneous function by encounters with commensals. J Physiol. 2017 Jan 15;595(2):437-450.

Bay L, Barnes CJ, Fritz BG et al. Universal Dermal Microbiome in Human Skin. mBio. 2020 Feb 11;11(1):e02945-19.

Bonté F, Girard D, Archambault JC, Desmoulière A. Skin Changes During Ageing. Subcell Biochem. 2019;91:249-280.

Shibagaki, N., Suda, W., Clavaud, C. et al. Aging-related changes in the diversity of women’s skin microbiomes associated with oral bacteria. Sci Rep 7, 10567 (2017).

Dreno B, Dagnelie MA, Khammari A, et al. The Skin Microbiome: A New Actor in Inflammatory Acne. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):18-24.

10 Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020 Aug 1;396(10247):345-360.

11 Rigon RB, de Freitas ACP, Bicas JL, et al. Skin microbiota as a therapeutic target for psoriasis treatment: Trends and perspectives. J Cosmet Dermatol. 2021;20(4):1066-1072.

12 Adalsteinsson JA, Kaushik S, Muzumdar S et al. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020;29(5):481-489

13 Tutka K, Żychowska M, Reich A. Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea-A Systematic Review of the Literature. Microorganisms. 2020;8(11):1756.

14 Yu Y, Dunaway S, Champer J, et al.Changing our microbiome: probiotics in dermatology. Br J Dermatol. 2020;182(1):39-46.

15 Seite S, Misery L. Skin sensitivity and skin microbiota: Is there a link? Exp Dermatol. 2018 Sep;27(9):1061-1064.

16 Johnson TR, Gomez BI, McIntyre MK, et al. The Cutaneous Microbiome and Wounds: New Molecular Targets to Promote Wound Healing. Int J Mol Sci. 2018;19(9):2699.

17 Schneider AM, Nelson AM. Skin microbiota: Friend or foe in pediatric skin health and skin disease. Pediatr Dermatol. 2019 Nov;36(6):815-822.

18 Szántó M, Dózsa A, Antal D, et al. Targeting the gut-skin axis-Probiotics as new tools for skin disorder management? Exp Dermatol. 2019 Nov;28(11):1210-1218.

19 FAO/OMS, Joint Food and Agriculture Organization of the United Nations/ World Health Organization. Working Group. Report on drafting  guidelines for the evaluation of probiotics in food, 2002.

20 Hill C, Guarner F, Reid G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11, 506–514 (2014).

21 Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics .J Nutr, 1995; 125:1401-12.

22 Gibson G, Hutkins R, Sanders M, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14, 491–502 (2017).

23  Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9):1021. Published 2017 Sep 15.

24 Bustamante M, Oomah BD, Oliveira WP, et al. Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract. Folia Microbiol (Praha). 2020;65(2):245-264.

25 Tap J, Furet JP, Bensaada M, et al. Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults. Environ Microbiol. 2015 Dec;17(12):4954-64. 

26 Quigley EMM, Gajula P. Recent advances in modulating the microbiome. F1000Res. 2020 Jan 27;9:F1000 Faculty Rev-46.

27 Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):35-56.

28 Wilson AS, Koller KR, Ramaboli MC, et al. Diet and the Human Gut Microbiome: An International Review. Dig Dis Sci. 2020;65(3):723-740.

BMI-21.13
 
Summary
On
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Microbiota

The ENT microbiota

The ENT (ear, nose, throat) microbiota is made up of three distinct bacterial floras: the oral microbiota, the auricular microbiota, and the nasopharyngeal microbiota.
Various diseases can result from their imbalance.

ENT microbiota

The term ENT includes three parts of the body: Ears, Nose, and Throat (which also includes the mouth).

  • The oral microbiota brings together more than 700 bacterial species, which contribute to oral health (teeth, gums, tongue, etc.) and, more generally, to overall health. A disruption in this equilibrium (dysbiosis), resulting from poor oral hygiene, a drop in immunity, or a genetic origin may lead to local infections (cavities, periodontitis, etc.) that are likely to migrate or cause more serious diseases, such as cardiovascular diseases. Hygiene and dental care remain the most effective method of prevention.
  • In the ear canal, the composition of the auricular microbiota is closely related to that of the skin. Recent work has shown the harmless presence of Alloiococcus otitis and Corynebacterium otitidis, two bacterial species that until now have only been associated with middle ear infections. This discovery suggests that the ear canal serves as an infectious reservoir for the middle ear.
  • Although close to the oral microbiota, the nasopharyngeal microbiota, which covers the nasal airways and the pharynx, is composed of very different germs.

Analyzing the realm of ENT and its microbiota may enable early diagnosis for various diseases that appear because of (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) and may also contribute to the development of personalized medicine based on probiotics.

International Microbiota Observatory

Discover the 2023 results
The Biocodex Microbiota Institute is dedicated to education about human Microbiota for General Public and Healthcare Professionals, it doesn't give any medical advice.
We recommend you to consult a healthcare professional to answer your questions and demands.
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Microbiota

The pulmonary microbiota

Why is the lung microbiota so important for health?

Researchers long held the view that the lungs of healthy individuals were sterile.1 That's not the case, though! It's just 10 years since medicine discovered the abundance of lung microbiota.2 Unlocking its secrets since then has proved a major challenge.

Pulmonary Tract Microbiota

What is the lung microbiota?

In contrast to its big brother, gut microbiota, it is only very recently that lung microbiota has been investigated. This delay can be partly explained by the difficulty of collecting samples and accessing the lungs themselves, both of which often require the use of an invasive method.3 In addition, the risk of bacterial infection of the upper airways is a real issue.4 Lung flora was first identified in 2010;5 there have since been very few studies devoted to elucidating the role of the communities of micro-organisms that live there.3  

Nonetheless, our understanding of the composition of the lung microbiota can be summed up in three points:

  • Low density of bacteria5
  • High level of biodiversity. In healthy individuals, bacteria from the Prevotella, Veillonella, Streptococcus, Neisseria, Fusobacterium and Haemophilus5 genera are predominant in the lungs. Maintaining the balance of this bacteria relies on the rhythm of inhalation and exhalation6
  • A tremendous abundance of “anaerobic” bacteria, which develop in the absence of oxygen. These are species of bacteria belonging to the Fusobacterium, Porphyromonas, Prevotella and Veillonella7 genera

Nor are bacteria the only (sidenote: Microorganisms Living organisms that are too small to be seen with the naked eye. They include bacteria, viruses, fungi, archaea and protozoa, and are commonly referred to as “microbes”. What is microbiology? Microbiology Society. ) that develop in the lung microbiota of healthy individuals! Fungi (species belonging to the Eremothecium, Systenostrema and Malassezia genera and to the Davidiellaceae family) and viruses (member species of the Anelloviridae family, along with a large number of (sidenote: Bacteriophage Virus that specifically targets and infects bacteria Scitable by Nature education_2014. Bacteriophage definition ) ) are also found to live there.2 Recent discoveries have also identified the presence of (sidenote: Archaea Type of micro-organism (different from bacteria) found in all environments, including extreme environments Archaea. Microbiology Society )  in the lungs.8 Lastly, while these micro-organisms form an integral part of the lung microbiota, the data currently available are limited. 

Why does the lung microbiota play a major role in our health?

The lung microbiota plays a key role in maintaining the balance of lung function. It acts in four major ways:

  • As a barrier to pathogens and an aid to resistance against respiratory infections,9 in exactly the same way as the gut microbiota
  • It plays a defensive role by actively helping to stimulate (sidenote: Innate and adaptive immunity  The human body protects itself using two kinds of defense mechanisms: innate immunity and adaptive immunity. Innate immunity is the first line of defense against disease agents and is an immediate response, while adaptive immunity is delayed but provides lasting protection Janeway CA Jr, Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease. 5th edition. New York: Garland Science; 2001. Principles of innate and adaptive immunity. ) in case of infections10,11
  • It is involved in the maturation of the pulmonary immune system, enabling, inter alia, tolerance to allergens12
  • It affects the morphology of the lungs and more specifically, the number of pulmonary alveoli, according to studies in mice13

Diseases linked to an imbalance in lung microbiota

When there is an imbalance in the composition of the lung microbiota, a (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) 14 emerges, which may be linked to various diseases. Scientific studies to date have not always been able to determine whether the dysbiosis causes or results from such diseases, though.

Let’s take a closer look at the disorders linked to pulmonary dysbiosis:

  • winter respiratory infections such as colds and flu (most often viral), where there is an imbalance in lung immunity, along with dysbiosis15 in the lungs and gut
  • asthma:16 a chronic disease of the respiratory system affecting more than 260 million people worldwide.17 This condition is associated with an imbalance in the lung microbiota,16 as well as in gut18 and nasal19 microbiota
  • cystic fibrosis, a rare genetic disease that mainly affects the airways and the digestive system20
  • chronic obstructive pulmonary disease (COPD), which is characterised by progressive narrowing and permanent obstruction of the airways and lungs, causing difficulty breathing16

The “gut-lung axis”

These conditions highlight the bidirectional communication between the gut and the lungs, known as the “gut-lung axis”.15 Gut microbiota plays a role in pulmonary immune response and lung diseases can also influence the composition of the intestinal microbiota.15 In fact, many respiratory diseases go hand in hand with gastrointestinal disorders21 and, conversely, intestinal dysbiosis is often linked to lung diseases.16 The involvement of this axis in pulmonary diseases is a highly promising area for research.22

Looking after your lung microbiota

You now know about the important role played by the lung microbiota and the gut-lung axis in your health. Researchers have grasped this fully and are currently investigating strategies to prevent or cure lung infections.23,24

When it comes to preventing winter respiratory infections, there have been some encouraging results when combining probiotics with prebiotics.25 In infants, certain probiotics may well prevent winter infections as early as the first few months of life.26 Lastly, some studies in students have demonstrated the value of using probiotic treatment to achieve a significant reduction in symptom duration.27,28
 

All the information in this article is derived from accepted scientific sources. It should be remembered that this information is not exhaustive. The list of studies from which this information has been extracted can be found here.     

Sources

Hufnagl K, Pali-Schöll I, Roth-Walter F, et al. Dysbiosis of the gut and lung microbiome has a role in asthma. Semin Immunopathol. 2020;42(1):75-93.

Barcik W, Boutin RCT, Sokolowska M, et al. The Role of Lung and Gut Microbiota in the Pathology of Asthma. Immunity. 2020;52(2):241-255.

Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol. 2017 Mar;10(2):299-306.

Dickson RP, Erb-Downward JR, Freeman CM, et al. Bacterial Topography of the Healthy Human Lower Respiratory Tract. mBio. 2017 Feb 14;8(1):e02287-16.

Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010 Jan 5;5(1):e8578.

Mathieu E, Escribano-Vazquez U, Descamps D, et al. Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma. Front Physiol. 2018 Aug 21;9:1168.v

Lamoureux C, Guilloux CA, Beauruelle C, et al. Anaerobes in cystic fibrosis patients' airways. Crit Rev Microbiol. 2019 Feb;45(1):103-117. 

Koskinen K, Pausan MR, Perras AK, et al. First Insights into the Diverse Human Archaeome: Specific Detection of Archaea in the Gastrointestinal Tract, Lung, and Nose and on Skin. mBio. 2017 Nov 14;8(6):e00824-17.

Brown RL, Sequeira RP, Clarke TB. The microbiota protects against respiratory infection via GM-CSF signaling. Nat Commun. 2017 Nov 15;8(1):1512.

10 Karmarkar D, Rock KL. Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response. Immunology. 2013 Dec;140(4):483-92.

11 Pichon M, Lina B, Josset L. Impact of the Respiratory Microbiome on Host Responses to Respiratory Viral Infection. Vaccines (Basel). 2017 Nov 3;5(4):40.

12 Gollwitzer ES, Saglani S, Trompette A, et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med. 2014 Jun;20(6):642-7.

13 Yun Y, Srinivas G, Kuenzel S, et al. Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture. PLoS One. 2014 Dec 3;9(12):e113466.

14 Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.

15 Dumas A, Bernard L, Poquet Y, et al. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Cell Microbiol. 2018 Dec;20(12):e12966.

16 Budden KF, Shukla SD, Rehman SF, et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med. 2019 Oct;7(10):907-920.

17 World Health Organization. 2021. Asthma. World Health Organization, Geneva, Switzerland. https://www.who.int/news-room/fact-sheets/detail/asthm

18 Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy. 2014 Jun;44(6):842-50.

19 Kang HM, Kang JH. Effects of nasopharyngeal microbiota in respiratory infections and allergies. Clin Exp Pediatr. 2021 Apr 15.

20 Hardouin P, Chiron R, Marchandin H, et al. Metaproteomics to Decipher CF Host-Microbiota Interactions: Overview, Challenges and Future Perspectives. Genes (Basel). 2021 Jun 9;12(6):892.

21 Sencio V, Machado MG, Trottein F. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunol. 2021 Mar;14(2):296-304.

22 Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017 Jan;15(1):55-63.

23 Park MK, Ngo V, Kwon YM, et al. Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PLoS One. 2013 Oct 4;8(10):e75368.

24 Belkacem N, Serafini N, Wheeler R, et al. Lactobacillus paracasei feeding improves immune control of influenza infection in mice. PLoS One. 2017 Sep 20;12(9):e0184976.

25 Pregliasco F, Anselmi G, Fonte L, et al. A new chance of preventing winter diseases by the administration of synbiotic formulations. J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S224-33.

26 Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study. Br J Nutr. 2009 Jun;101(11):1722-6.

27 Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013 Jun;109(11):1999-2007.

28 Wang Y, Li X, Ge T, et al. Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016 Aug;95(31):e4509.

BMI-21.41

International Microbiota Observatory

Discover the 2023 results
Summary
On
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Microbiota

The urinary microbiota

The urinary microbiota: what is it and why is it so important for our health?

The human urinary tract is inhabited by numerous microorganisms that can play a protective role in our health.1 Reduced diversity in the urinary flora may also be a risk factor for disease.2 In fact, urine was once thought to be sterile, but recent scientific research has shown the opposite to be the case.2 Continue reading to see how research on the urinary microbiota is evolving.

Urinary microbiota

What is exactly the human urinary microbiota?

You have probably heard less about the urinary microbiota than its more well-known neighbors, the gut microbiota and the vaginal microbiota. This is no surprise, since it is a less rich and diverse environment3 whose role requires further research.1

However, recent studies have shown that the urinary tract is home to a unique urinary microbiota.4,5 Urine analyses based on culture-dependent methods have traditionally identified (sidenote: Pathogens A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) responsible for urinary tract infections (UTIs), such as Escherichia coli.

Advances in detection technologies have led to the discovery of additional bacteria in the urinary microbiota. The genus Lactobacillus is frequently identified, while Gardnerella, Streptococcus, and Corynebacterium also tend to be present, although to a lesser degree.3 In addition, communities of fungi have also been observed.6 

Moreover, although the number of studies in the area remains limited, the composition of the urinary microbiota of women appears to be different from that of men,7 which is not surprising given the anatomical and hormonal differences between the two sexes.

Why is the urinary microbiota a key player in our health?

(sidenote: Microorganisms Living organisms that are too small to be seen with the naked eye. They include bacteria, viruses, fungi, archaea and protozoa, and are commonly referred to as “microbes”. What is microbiology? Microbiology Society. ) inhabiting the urinary microbiota can play a protective role in our health.1 However, under certain conditions, they can also influence urinary tract infections.2

Several mechanisms have been described: for example, the bacterial genera Lactobacillus and Streptococcus secrete lactic acid, which is believed to play a protective role against pathogens.8 Lactic acid lowers the pH of urine (≈ 4.5), creating a microenvironment that is hostile to most pathogenic bacteria.

Furthermore, (sidenote: Lactobacilli Rod-shaped bacteria whose main characteristic is the production of lactic acid, from where they get the name “lactic acid bacteria”.  Lactobacilli are present in the oral, vaginal and gut microbiota of humans, but also in plants and animals. They are found in fermented foods, such as dairy products (e.g. certain cheeses and yoghurts), pickles, sauerkraut, etc. Lactobacilli are also found in probiotics, with certain species recognized for their beneficial properties.   W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria, 2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004 Jun;70(6):3189-94. Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013 Jun;109(11):1999-2007. ) produces additional substances, antibacterial metabolites such as hydrogen peroxide, which also protect against pathogens.9 As with the gut microbiota, the urinary microbiota acts as a barrier against pathogens.1

What diseases are associated with an unbalanced urinary microbiota?

As with all microbiota (gut microbiota, lung microbiota, etc.), when the composition of the urinary microbiota is disrupted, an imbalance, or “ (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) ”,9 results. Studies comparing the urinary microbiota of healthy subjects to that of patients suffering from various urinary diseases have identified a link between these diseases and the composition of the urinary microbiota.

In fact, studies published to date have demonstrated a clear role for the urinary microbiota in urinary tract infections (UTIs).8,10 For example, decreased diversity in the urinary microbiota may be a risk factor for urinary tract infections.11

Furthermore, disorders such as urgency urinary incontinence,12 interstitial cystitis,13 and sexually transmitted infections14 have also been associated with an altered urinary microbiota.

How can we take care of our microbiota? We can have a direct influence on it.

  • Diet: it is common knowledge that dietary factors can influence the risk of urinary tract infections. Certain food and dietary products (such as cranberry juice or fermented dairy products containing probiotics) may help reduce the risk of recurrent infection by regulating the microbiota.8

  • Probiotics: oral and vaginal probiotic have been successful in decreasing recurrence rates for UTIs.15

  • Water: drinking plenty of water is important, but researchers have not yet confirmed that it can cure UTIs.1

All the information in this article comes from scientific approved sources. Keep in mind this is not exhaustive. Here are all the studies from which we took all of that information.

References

Whiteside SA, Razvi H, Dave S, et al. The microbiome of the urinary tract--a role beyond infection. Nat Rev Urol. 2015 Feb;12(2):81-90.

2 Morand A, Cornu F, Dufour JC, et al. Human Bacterial Repertoire of the Urinary Tract: a Potential Paradigm Shift. J Clin Microbiol. 2019 Feb 27;57(3). 

Brubaker L, Wolfe AJ. The female urinary microbiota, urinary health and common urinary disorders. Ann Transl Med. 2017 Jan;5(2):34.

4 Hilt EE, McKinley K, Pearce MM, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014 Mar;52(3):871-6.

Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014 Jul 8;5(4):e01283-14.

6 Ackerman AL, Underhill DM. The mycobiome of the human urinary tract: potential roles for fungi in urology. Ann Transl Med. 2017 Jan;5(2):31. 

Lewis DA, Brown R, Williams J, et al. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol. 2013 Aug 15;3:41.

8 Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, et al. The Urinary Tract Microbiome in Health and Disease. Eur Urol Focus. 2018 Jan;4(1):128-138. 

9 Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232

10 Antunes-Lopes T, Vale L, Coelho AM, et al. The Role of Urinary Microbiota in Lower Urinary Tract Dysfunction: A Systematic Review. Eur Urol Focus. 2020 Mar 15;6(2):361-369. 

11 Horwitz D, McCue T, Mapes AC, et al. Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference. J Infect. 2015 Sep;71(3):358-367.

12 Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014 Jul 8;5(4):e01283-14.

13 Siddiqui H, Lagesen K, Nederbragt AJ, et al. Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol. 2012 Sep 13;12:205.

14 Nelson DE, Van Der Pol B, Dong Q, et al. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One. 2010 Nov 24;5(11):e14116.

15 Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011 May;52(10):1212-7.

BMI-21.12
Summary
On
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Microbiota

The gut microbiota

Gut microbiota: why is it that important for your health?
We have trillions1 of bacteria that populate our intestine with fascinating powers on the human body. Let’s understand how your intestinal microbiota works and why you should take care of it! 

The Gut microbiota

What is exactly the human gut microbiota?

You probably have already heard about the “gut flora”, well, scientifically, it is called “the intestinal microbiota” or to put it more simply “the gut microbiota”. What is the definition of gut microbiota ? It consists of trillions1 of (sidenote: Microorganisms Living organisms that are too small to be seen with the naked eye. They include bacteria, viruses, fungi, archaea and protozoa, and are commonly referred to as “microbes”. What is microbiology? Microbiology Society. ) that populate your intestines like bacteria, viruses, fungi (including yeasts), and even parasites.

By the way, microbiota and microbiome are two words often used as one to the other but they have two different meanings while microbiota is used to talk about the microorganism and answer the question “who is there?” basically the “individuals”, the microbiome talks about their genome “what is inside of them”2 to answer the question “what are they doing” meaning their function.

Each one of us has a unique microbiota, like a fingerprint.1 When you’re born, fecal and vaginal microorganisms transmitted by your mother during vaginal delivery, or environmental microorganisms for cesarean delivery,3 induce the start of your gut microbiota colonization4. It takes around three years for the gut microbiota to build up, diversify and stabilize.5 During adulthood,6 the composition is relatively stable until old age when it undergoes profound changes again to become slightly impoverished.7

100 000 100,000 billion “good” bacteria live in our gut

2nd the gut microbiota is often considered as the second brain

Why is gut microbiota important for your health?

The gut microbiota can be considered a functional organ of the human body. Why should we take care of our microbiota ? It works closely with your intestines and have 4 important roles:

It promotes digestion

by helping with the absorption of nutrients (sugars, amino acids, vitamins…) by intestinal cells or with the fermentation of the small fraction of food. These fermentation processes produce gas and numerous metabolites, including short-chain fatty acids, a real “fuel” for the cells in your colon.8

It plays an important role in the maturation of the digestive tract

by having an active role in the production of gastrointestinal mucus, the irrigation of intestinal cells, and the enzymatic activity of the mucosa.9

It works as a barrier

against pathogens and toxins.10 Furthermore, some bacteria release antimicrobial molecules against the (sidenote: Pathogens A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) bacteria while others stimulate the production of mucus to protect intestinal cells from attacks and avoid harmful effects on your body.11

It plays a defensive role

in developing the human immune system. Bacteria of the gut flora are involved in the maturation and activation of cells in the intestinal immune system, which protects you from attacks by pathogenic agents like bacteria and viruses. The intestine is the primary reservoir for immune cells in your body. For its part, the immune system influences the composition and diversity of microbiota.12

What affects your gut microbiota ?

The composition of the gut microbiota is characterized by its high diversity (number of different species present in an individual) and its abundance (total number of microorganisms present). When the composition is disrupted, the balance is broken, and a  (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) emerges,13 which can be associated with several diseases. 

Numerous factors can have an impact on the diversity and composition of the gut microbiota. Among these factors, these are the following:

Factors linked to the individual themselves, such as:

  • The age6
  • Genetics13 
  • Certain illnesses and injuries13 

Others factors are linked to the individual's environment:

  • Medication use: antibiotics, anti-inflammatories, etc.8 
  • Infections (viral gastroenteritis…)13
  • Lifestyle: unbalanced diet (high-fat diet for example), or changes in diet, stress, smoking, alcoohol excess, etc. 13

What are the diseases that could be linked to gut microbiota ?

Dysbiosis, cause or consequence of these diseases? The question has not yet been answered with certainty by scientific studies.

Let’s have a look to some diseases associated with intestinal dysbiosis:

  • Infantile colic 14 that affects 20 to 25% of infants between the age of 1 and 4 months

  • Antibiotics associated diarrhea, which happens between 5 and 35% of patients taking antibiotics15

  • Traveler’s diarrhea is an infection caused by contaminated food or contaminated. Postinfectious irritable bowel syndrome may occur in 3% to 17% of patients who had this infection16

  • Gastroenteritis generally benign and most often viral is responsible for over 200,000 deaths of children per year worldwide17

  • Obesity is a common, costly, and serious chronic disease that affected 13% of the world’s adult population (11% of men and 15% of women) in 201618

  • IBS is one of the most functional gastrointestinal disorders characterized by abdominal pain and alterations in the host’s bowel habits (constipation, diarrhea, or alternations). The prevalence varies substantially between countries19

  • Crohn’s disease is an inflammatory bowel disease, where inflammation can be localized at all stages of the digestive system, from the mouth to the anus. Recent studies provide evidence that the gut microbiota plays an important function in the etiopathogenesis of this disease20

  • Stomach cancer21 and colorectal cancer22 are two gastrointestinal cancers associated with gut microbiota dysbiosis

But the role of the human gut microbiota doesn’t stop at the gut: recent studies have identified that the gut microbiota may play a role beyond the gastrointestinal tract. In fact, gut microbiota has been associated with several extra-intestinal diseases: for example, acne23 , allergies24 , obesity,25 anxiety disorders,26 autism-spectrum disorders26…And that’s not all of it. It seems that gut microbiota can also be associated with neurodegenerative diseases like Alzheimer’s,27 Parkinson’s.28 In fact, there is bidirectional communication between the gut and the brain, named “gut- brain- axis”, and gut microbiota could influence these interactions. That is why your gut is sometimes called your second brain.

How to take care of your microbiota?

You know by now the central role of the gut microbiota in human health. So how should you take care of your own microbiota? How to improve your gut microbiota ? Many scientific studies raised the question of how to avoid any disruption in its composition and keep it as balanced as possible.29 The answer is not as simple as bring in good bacteria or yeast to fill or enrich the existing microbiota or replace the bad ones. In fact, the idea is to influence the microbiota to help it to function smoothly thereby improving host health.30

You have several ways of positively affecting the balance and the diversity of the gut microbiota :

  • Diet: the diversity and quality of what we eat contribute to the balance in our intestinal microbiota.31,32 On the other hand, a poorly balanced diet can affect the composition of our gut and lead to some conditions.33 It is important to know what type of food has a beneficial effect or a negative one to keep our gut in shape!34

  • Probiotics: Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.35,36 

  • Prebiotics: Prebiotics are specific non-digestible dietary fibers conferring a health benefit, they are selectively utilized by beneficial microorganisms in the host’s microbiota.37,38 Some foods are particularly rich in prebiotics, that’s why it is important to pay attention to our diet. When they are added to probiotics in some specific products, we call them symbiotics.39

  • Transplant: as for the organs, gut microbiota can be transferred to an individual in an attempt to restore equilibrium amongst the gut microbial ecosystem.32 Known as fecal microbiota transplant (FMT), this therapeutic approach is only validated to cure recurrent Clostridioides difficile–associated disease32 and is still under active research to evaluate its effect on other specific health conditions such as Crohn's disease, ulcerative colitis, irritable bowel syndrome, or metabolic disease32

Oh! one more thing...

Now that you have read everything you need to know about the gut microbiota, you should also know that you have microorganisms all along the body: in your skin,40 your urinary tract,41 your vagina,42 your mouth,43 your ears,44 your lungs,45 and, as it does for the intestine, the microorganisms that live there play a tremendous role to keep them functioning and maintain you in health. To know more visit this page.

The Biocodex Microbiota Institute is dedicated to education about human Microbiota for General Public and Healthcare Professionals, it doesn't give any medical advice.
We recommend you to consult a healthcare professional to answer your questions and demands.

All the information in this article comes from scientific approved sources. Keep in mind this is not exhaustive. Here are all the studies from which we took all of that information

International Microbiota Observatory

Discover the 2023 results
BMI 21.10
Sources

1 Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006 Feb 24;124(4):837-48.

2 Ursell LK, Metcalf JL, Parfrey LW, et al. Defining the human microbiome. Nutr Rev. 2012;70 Suppl 1(Suppl 1):S38-S44.

3 Callaway E. C-section babies are missing key microbes [published online ahead of print, 2019 Sep 18]. Nature. 2019;10.1038/d41586-019-02807-x. 

4 Sandall J, Tribe RM, Avery L, et al. Short-term and long-term effects of caesarean section on the health of women and children. Lancet. 2018;392(10155):1349-1357.

5 Bäckhed F, Roswall J, Peng Y, et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of LifeCell Host Microbe. 2015;17(5):690-703.

6 Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012 May 9;486(7402):222-7.

7 Ragonnaud E, Biragyn A. Gut microbiota as the key controllers of "healthy" aging of elderly people. Immun Ageing. 2021 Jan 5;18(1):2. 

8 Jandhyala SM, Talukdar R, Subramanyam C, et al. Role of the normal gut microbiota. World J Gastroenterol. 2015 Aug 7;21(29):8787-803.

9 Tomas J, Wrzosek L, Bouznad N, B, et al. Primocolonization is associated with colonic epithelial maturation during conventionalization. FASEB J. 2013 Feb;27(2):645-55.

10 Caballero S, Pamer EG. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol. 2015;33:227-56.

11Sokol H. Microbiota and barrier effect. In: Marteau P, Dore J, eds. Gut Microbiota: A Full-Fledged Organ. Paris: John Libby Eurotext; 2017:65-71.

12 Brandtzaeg P. Role of the Intestinal Immune System in Health. In:  Baumgart, Daniel C, eds. Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer International Publishing; 2017

13 Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.

14 Perceval C, Szajewska H, Indrio F, et al. Prophylactic use of probiotics for gastrointestinal disorders in children. Lancet Child Adolesc Health. 2019 Sep;3(9):655-662.

15 McFarland LV. Antibiotic-associated Diarrhea: Epidemiology, Trends and Treatment. Future Microbiol. 2008 Oct;3(5):563-78.

16 Steffen R, Hill DR, DuPont HL. Traveler's diarrhea: a clinical review. JAMA. 2015 Jan 6;313(1):71-80. 

17 Stuempfig ND, Seroy J. Viral Gastroenteritis. In: StatPearls. Treasure Island (FL): StatPearls

18 WHO. Fact sheets on obesity and overweight June 2021

19 Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):908-917. 

20 Aldars-García L, Marin AC, Chaparro M, et al. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review. Int J Mol Sci. 2021 Mar 17;22(6):3076.

21 Nasr R, Shamseddine A, Mukherji D, et al. The Crosstalk between Microbiome and Immune Response in Gastric Cancer. Int J Mol Sci. 2020 Sep 9;21(18):6586. 

22 Ranjbar M, Salehi R, Haghjooy Javanmard S, et al. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review. Cancer Cell Int. 2021;21(1):194. 

23 Dreno B, Dagnelie MA, Khammari A, et alThe Skin Microbiome: A New Actor in Inflammatory Acne. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):18-24.

24 Houghteling PD, Walker WA. From Birth to "Immunohealth," Allergies and Enterocolitis. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1(0 1):S7-S12

25 Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006 Dec 21;444(7122):1022-3. 

26 Maiuolo J, Gliozzi M, Musolino V, et al. The Contribution of Gut Microbiota-Brain Axis in the Development of Brain Disorders. Front Neurosci. 2021 Mar 23;15:616883. 

27 Qian XH, Song XX, Liu XL, et al. Inflammatory pathways in Alzheimer's disease mediated by gut microbiota. Ageing Res Rev. 2021 Mar 9;68:101317.

28 Lorente-Picón M, Laguna A. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules. 2021 Mar 15;11(3):433. 

29 ILSI Europe, 2013 Probiotics, Prebiotics and the Gut Microbiota. ILSI Europe Concise Monograph. 2013:1-32.

30 Quigley EMM. Prebiotics and Probiotics in Digestive Health. Clin Gastroenterol Hepatol. 2019;17(2):333-344.

31 Tap J, Furet JP, Bensaada M, et al. Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults. Environ Microbiol. 2015 Dec;17(12):4954-64. 

32 Quigley EMM, Gajula P. Recent advances in modulating the microbiome. F1000Res. 2020;9:F1000 Faculty Rev-46. Published 2020 Jan 27.

33 Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):35-56

34 Wilson AS, Koller KR, Ramaboli MC, et al. Diet and the Human Gut Microbiome: An International Review. Dig Dis Sci. 2020;65(3):723-740. 

35 FAO/OMS, Joint Food and Agriculture Organization of the United Nations/ World Health Organization. Working Group. Report on drafting  guidelines for the evaluation of probiotics in food, 2002.

36 Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.

37 Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics .J Nutr, 1995; 125:1401-12.

38 Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502.

39 Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9):1021.

40 Bay L, Barnes CJ, Fritz BG, et al. Universal Dermal Microbiome in Human Skin. mBio. 2020;11(1):e02945-19. 

41 Neugent ML, Hulyalkar NV, Nguyen VH, et alAdvances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection. mBio2020 Apr 28;11(2):e00218-20.

42 Greenbaum S, Greenbaum G, Moran-Gilad J, et al. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019 Apr;220(4):324-335.

43 Radaic A, Kapila YL. The oralome and its dysbiosis: New insights into oral microbiome-host interactions. Comput Struct Biotechnol J. 2021 Feb 27;19:1335-1360.

44 Xu Q, Gill S, Xu L, et al. Comparative Analysis of Microbiome in Nasopharynx and Middle Ear in Young Children With Acute Otitis Media. Front Genet. 2019;10:1176.

45 Mathieu E, Escribano-Vazquez U, Descamps D, et alParadigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma. Front Physiol. 2018 Aug 21;9:1168.

Summary
On
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Microbiota